The author discusses how Principal Care Management (PCM) enhances oncology care, improves patient outcomes, and boosts ...

In a significant research advancement that may help inform treatment strategies for millions of patients worldwide, a ...

The intervention being tested is Benralizumab, a biological treatment administered subcutaneously. It is designed to reduce COPD exacerbations by targeting elevated eosinophils in the blood, which are ...

The presence of gastroesophageal reflux disease (GERD) is associated with an increased incidence of pulmonary diseases, but ...

Columnist Caroline Gainer shares the recipe for her morning "magic coffee" and explains how each ingredient benefits her ...

Scannapieco, who recently received the 2025 International Association for Dental, Oral and Craniofacial Research (IADR) ...

Metformin, rapamycin, and senolytics show multifaceted effects on aging biology that could transform how clinicians approach ...

Impacts of long COVID show that child development and ability to complete an education can suffer significantly. Little is ...

"I'm a nurse. No one knows just how short-staffed all positions in the hospital are. Short on doctors. Short on nurses. Short ...

Humans are programmed to follow intellectual fashions. In the field of chronic obstructive pulmonary disease (COPD), the concept that inflammation is the core problem is dominant, whereas other key ...

Floodwaters are “a toxic brew of pesticides, toxins, petroleum, anything and everything that you can imagine,” said Dr.

An individual treatment effect model may identify patients with COPD in whom azithromycin treatment would likely prevent acute exacerbations.